ask="5.10"
ask_size="600"
average_daily_volume="207111"
bid="5.10"
bid_size="100"
book_value="3.27"
change="-0.35"
change_from_200_day_moving_average="-5.26"
change_from_50_day_moving_average="-1.02"
change_from_52_week_high="-12.60"
change_From_52_week_low="0.00"
change_in_percent="-6.42%"
close="5.10"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.53"
ebitda="-19.35M"
eps_estimate_current_year="-2.81"
eps_estimate_next_quarter="-0.93"
eps_estimate_next_year="-2.55"
ex_dividend_date="N/A"
float_shares="5820000"
high="5.50"
high_52_weeks="17.70"
last_trade_date="1/19/2017"
last_trade_price="5.10"
last_trade_size="150"
last_trade_time="3:59pm"
low="5.10"
low_52_weeks="5.10"
market_capitalization="39.87M"
moving_average_200_day="10.36"
moving_average_50_day="6.12"
name="Trillium Therapeutics Inc."
notes="N/A"
one_year_target_price="16.86"
open="5.50"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-50.76%"
percent_change_from_50_day_moving_average="-16.72%"
percent_change_from_52_week_high="-71.19%"
percent_change_from_52_week_low="+0.00%"
previous_close="5.45"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.67"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="7817000"
short_ratio="1.46"
stock_exchange="NCM"
symbol="TRIL"
volume="156794"
weeks_range_52="5.10 - 17.70"
